Decoding Brain Bleeds: Can a New Scale Predict Recovery After Aneurysm?
"The BNI grading scale offers a simpler way to assess SAH and predict outcomes, potentially improving patient care and treatment strategies."
When an aneurysm ruptures and causes bleeding in the brain (aneurysmal subarachnoid hemorrhage, or aSAH), predicting how well a person will recover is a major challenge. A key complication is delayed cerebral ischemia (DCI), where blood supply to the brain is reduced, potentially causing further damage. Doctors have long relied on the Fisher scale to estimate this risk, but a newer tool, the Barrow Neurological Institute (BNI) scale, aims to provide a more straightforward and accurate assessment.
The BNI scale focuses on the thickness of blood accumulation in the brain after the bleed, offering a quantitative measure that could potentially replace or enhance the traditional Fisher score. Researchers from Switzerland undertook a large, nationwide study to validate the BNI scale and determine its effectiveness in predicting DCI and overall patient outcomes.
This article will explore the findings of that study, explaining how the BNI scale works, its potential benefits over existing methods, and what it means for people at risk of aSAH and the medical professionals who care for them. We'll break down the key results and discuss how this new tool could lead to improved treatment strategies and better recovery prospects.
The Long Reach of Aneurysmal SAH
About 30,000 people in the United States suffer a brain aneurysm rupture each year, while the annual rupture rate is approximately 8–10 per 100,000 people. Long-term mortality after subarachnoid hemorrhage has been reported at 17.9% at 10 years, 29.5% at 15 years, and 43.6% at 20 years. Survivors of aneurysmal subarachnoid hemorrhage have also shown 17% excess mortality compared with the general population after 20 years.
Securing the Aneurysm
Once a bleeding aneurysm is identified, the ultimate therapeutic goal is to secure it surgically by coiling or clipping. The 2024 clinical review describes critical care priorities as maintaining cerebral perfusion, securing the aneurysm early, and preventing secondary brain injury and systemic complications. Treatment may also involve removing large collections of blood or relieving pressure on the brain when the subarachnoid hemorrhage is related to an injury.
Understanding the Hemorrhage
Subarachnoid hemorrhage is defined as the extravasation of blood into the subarachnoid space between the pial and arachnoid membranes. Clinical references identify smoking and a previously ruptured intracerebral aneurysm as factors strongly associated with a new subarachnoid hemorrhage. Recovery from an aneurysmal bleed can take much longer than the initial emergency treatment, with Barrow Neurological Institute describing two weeks of in-hospital care to treat the after-effects of subarachnoid hemorrhage.
The BNI Scale: A Simpler Way to Assess Risk
The BNI scale is designed to be a practical tool for doctors. Instead of complex assessments, it relies on a single measurement: the maximum thickness of the blood clot in any of the brain's fissures or cisterns (spaces around the brain). This measurement is taken from CT scans performed upon admission to the hospital.
- BNI Grade 1: No visible SAH
- BNI Grade 2: Clot thickness measured till 2mm
- BNI Grade 3: Clot thickness measured till 4mm
- BNI Grade 4: Clot thickness measured till 6mm
- BNI Grade 5: Clot thickness measured more than 6mm
A More Comprehensive Research Agenda
A 2025 systematic review examined the outcome measures used in aneurysmal subarachnoid hemorrhage clinical research. A 2026 update emphasizes that diagnosing and treating aSAH requires a comprehensive approach delivered by a multidisciplinary team. Together, these sources point to continued attention not only to treatment, but also to how recovery and outcomes are measured.
Recovery Is Not Always Complete
Recovery from aneurysmal subarachnoid hemorrhage is often incomplete and may include subtle but persistent cognitive deficits. Harvard Health reports that recovery is usually slow and that most survivors do not regain complete functioning within months. A clinical summary from Mayfield Clinic divides outcomes into roughly one-third surviving with good recovery, one-third surviving with disability, and one-third dying, illustrating why apparent survival does not necessarily mean full recovery.
Aneurysm and Stroke Are Not Synonyms
A ruptured brain aneurysm can cause a hemorrhagic stroke, but not all hemorrhagic strokes are caused by aneurysms. The distinction matters because aneurysm rupture is one specific cause within the broader category of hemorrhagic stroke. Comparing the conditions without separating cause from event can therefore obscure differences in diagnosis and treatment.
The Future of Brain Bleed Assessment
The Swiss study provides strong evidence that the BNI scale is a valuable tool for predicting DCI and outcomes after aSAH. Patients with higher BNI grades (indicating thicker blood accumulation) were significantly more likely to develop DCI and experience unfavorable outcomes. Importantly, the BNI scale also allowed for further risk stratification within the large group of patients classified as Fisher 3, where the traditional scale provides limited differentiation.
Favorable Recovery Is Possible
A comprehensive systematic review cited in a case report found that approximately one-third of patients with aneurysmal subarachnoid hemorrhage achieve a favorable functional outcome. That figure underscores both the seriousness of aSAH and the fact that meaningful recovery occurs for a substantial minority. Individual outcomes can therefore differ markedly from the overall prognosis.
More Survivors, Longer Recovery Questions
A 2011 review reported that more patients are surviving aneurysmal subarachnoid hemorrhage, with case fatality decreasing by 17% in absolute terms over the preceding three decades. A 2025 report discusses a proposed one-year rule, stating that beyond that point survivors may reach a plateau and their deficits may become permanent. At the same time, rehabilitation remains important because treatment improvements have contributed to a rapid rise in the number of aSAH survivors and neurocognitive sequelae remain a concern.
Recovery Has No Fixed Timeline
Recovery from subarachnoid hemorrhage is highly individual, with no set timeline or universal pattern. The first weeks and months are described as critical for preventing further complications. This variability makes recovery difficult to summarize with a single expected milestone for every patient.
Exceptional Recoveries
A Cleveland Clinic case study describes a 38-year-old who survived a grade 5 brain aneurysm, despite a reported 90% fatality rate, and returned to many daily activities. Michigan Medicine reported another woman who said she was completely back to normal after a near-fatal brain aneurysm bleed. These cases show that individual recovery can exceed expectations, although they are examples of particular patients rather than evidence of typical outcomes.
While the BNI scale showed promise, the researchers also found that combining it with the World Federation of Neurological Surgeons (WFNS) score (a measure of a patient's clinical condition upon admission) and patient age further improved the prediction of outcomes. This suggests that a multi-faceted approach, incorporating both radiological and clinical data, may provide the most accurate assessment.
The BNI scale offers a simple, quantitative, and reliable way to assess the risk of DCI and predict outcomes after aSAH. As research continues, expect to see a refinement of risk assessment strategies. The BNI scale could play a vital role in improving treatment decisions and ultimately improving the lives of those affected by this devastating condition. The focus is to help improve treatment decisions and the lives of those affected by this devastating condition.